Saturday 17 October 2026
Export CUPR’s income statement to Excel — free account
Cuprina Holdings (Cayman) Limited
CUPR Healthcare Medical Instruments & Supplies
Cuprina Holdings (Cayman) Limited’s revenue for fiscal 2025 (year ended December 2025) was $38,800.00, up 9.30% from fiscal 2024.
1.90
0.05
−2.56%
Follow CUPR
| Dec '25 | Jun '25 | Dec '24 | |
|---|---|---|---|
Current Ratio |
2.35 | 3.58 | 0.27 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 |
Debt/Assets |
4.38% | 1.77% | 12.55% |
Debt/Equity |
0.07 | 0.03 | (0.05) |
Operating CF/Net income |
0.00 | 0.00 | 0.00 |
Capex/Depreciation |
(1.60) | (0.29) | (0.52) |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 |
Free Cash Flow |
(7.15) | (6.46) | (0.93) |
Working Capital |
3.28 | 6.08 | (3.22) |
Capital Expenditures |
(0.05) | 0.00 | (0.02) |
Net Current Asset Value |
3.02 | 5.97 | (3.34) |
| Other line items | |||
Quick Ratio |
1.08 | 1.44 | 0.04 |
Operating CF per Share |
0.00 | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Columns are period end dates